Insider Transactions in Q4 2021 at Theseus Pharmaceuticals, Inc. (THRX)
Insider Transaction List (Q4 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 21
2021
|
Bradford D. Dahms President and CFO |
BUY
Open market or private purchase
|
Direct |
1,970
+50.0%
|
$19,700
$10.15 P/Share
|
|
Dec 21
2021
|
Timothy P Clackson President and CEO |
BUY
Open market or private purchase
|
Direct |
2,600
+0.74%
|
$23,400
$9.76 P/Share
|
|
Oct 12
2021
|
Takeda Pharmaceutical CO LTD > 10% Shareholder |
BUY
Conversion of derivative security
|
Indirect |
1,615,427
+50.0%
|
-
|
|
Oct 12
2021
|
Omega Fund Vi, L.P. |
BUY
Open market or private purchase
|
Direct |
187,500
+20.86%
|
$3,000,000
$16.0 P/Share
|
|
Oct 12
2021
|
Omega Fund Vi, L.P. |
BUY
Conversion of derivative security
|
Direct |
523,979
+50.0%
|
-
|
|
Oct 12
2021
|
William Shakespeare Officer |
BUY
Open market or private purchase
|
Direct |
625
+0.16%
|
$10,000
$16.0 P/Share
|
|
Oct 12
2021
|
Carl L Gordon Director |
BUY
Open market or private purchase
|
Indirect |
625,000
+7.23%
|
$10,000,000
$16.0 P/Share
|
|
Oct 12
2021
|
Carl L Gordon Director |
BUY
Conversion of derivative security
|
Indirect |
16,213,668
+50.0%
|
-
|
|
Oct 12
2021
|
Orbimed Advisors LLC Director |
BUY
Open market or private purchase
|
Indirect |
625,000
+7.23%
|
$10,000,000
$16.0 P/Share
|
|
Oct 12
2021
|
Orbimed Advisors LLC Director |
BUY
Conversion of derivative security
|
Indirect |
16,213,668
+50.0%
|
-
|
|
Oct 12
2021
|
Rock Springs Capital Management LP > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
250,000
+29.44%
|
$4,000,000
$16.0 P/Share
|
|
Oct 12
2021
|
Rock Springs Capital Management LP > 10% Shareholder |
BUY
Conversion of derivative security
|
Indirect |
436,649
+50.0%
|
-
|